How to manage hypernatremia (elevated sodium levels) in a patient at risk of Osmotic Demyelination Syndrome (ODS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypernatremia in Patients at Risk for Osmotic Demyelination Syndrome (ODS)

For patients with hypernatremia at risk of Osmotic Demyelination Syndrome (ODS), correction should be gradual with a maximum rate of 4-6 mmol/L per day, not exceeding 8 mmol/L in any 24-hour period, using hypotonic fluids while avoiding salt-containing solutions. 1

Risk Assessment for ODS

Patients at high risk for ODS include those with:

  • Chronic liver disease/cirrhosis
  • History of alcoholism
  • Malnutrition
  • Hypokalemia
  • Severe or prolonged hypernatremia (especially >160 mmol/L)
  • Previous rapid sodium corrections

Treatment Algorithm

1. Initial Management

  • Fluid Selection:
    • Use hypotonic fluids (5% dextrose in water) 1
    • Avoid salt-containing solutions (especially 0.9% NaCl) as they increase renal osmotic load and can worsen hypernatremia 2
    • For every 1L of isotonic fluid given, approximately 3L of urine may be needed to excrete the osmotic load in patients with impaired concentrating ability 2

2. Correction Rate

  • Target correction rate: 4-6 mmol/L per day 1
  • Maximum safe limit: 8 mmol/L in any 24-hour period 1
  • Calculate initial fluid rate based on physiological demand:
    • Adults: 25-30 ml/kg/24h 2
    • Children: First 10 kg: 100 ml/kg/24h; 10-20 kg: 50 ml/kg/24h; remaining weight: 20 ml/kg/24h 2

3. Monitoring

  • Serum sodium: Every 2-4 hours initially in symptomatic patients 1
  • Fluid status: Daily weight measurements 1
  • Neurological status: Regular assessments for signs of neurological deterioration

4. Managing Overcorrection

If sodium decreases too rapidly (>8 mmol/L in 24 hours):

  • Consider DDAVP (desmopressin) to prevent further rapid drops in sodium 3
  • Hypertonic saline may be needed to re-elevate sodium levels if symptoms of ODS appear 4

5. Addressing Underlying Causes

  • Diabetes Insipidus: Consider appropriate medications (DDAVP for central DI)
  • Excessive Free Water Loss: Treat underlying conditions (fever, diarrhea)
  • Iatrogenic Causes: Adjust medication regimens that may contribute to hypernatremia

Special Considerations

Patients with Nephrogenic Diabetes Insipidus

  • Low salt diet (≤6 g/day) and protein restriction (<1 g/kg/day) 2
  • Consider diuretics (thiazides, potassium-sparing) to reduce polyuria 2
  • Prostaglandin synthesis inhibitors may enhance water reabsorption 2

Recognizing Early ODS

Early symptoms of ODS typically present 2-7 days after rapid sodium correction:

  • Initial seizures or encephalopathy
  • Brief improvement followed by clinical deterioration
  • Tremors, rigidity, decreased consciousness 5

Pitfalls to Avoid

  1. Overly rapid correction: Despite the risk of ODS with rapid correction, a meta-analysis showed that rapid correction was associated with lower in-hospital mortality (RR, 0.51) and shorter hospital stays, though with increased ODS risk (RR, 3.91) 6. This highlights the need for balanced correction.

  2. Using salt-containing solutions: Normal saline can worsen hypernatremia in patients with impaired concentrating ability 2.

  3. Inadequate monitoring: Failure to monitor sodium levels frequently during correction can lead to missed opportunities to adjust treatment.

  4. Ignoring risk factors: ODS can occur even with cautious correction in high-risk patients 5, emphasizing the need for extra vigilance in these cases.

  5. Delayed recognition of ODS: If ODS symptoms develop, early intervention with re-lowering of sodium may improve outcomes if initiated within 4-8 hours of symptom onset 4.

By following these guidelines, clinicians can effectively manage hypernatremia while minimizing the risk of ODS, which carries significant morbidity and mortality.

References

Guideline

Management of Dilutional Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rate of Sodium Correction and Osmotic Demyelination Syndrome in Severe Hyponatremia: A Meta-Analysis.

Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures), 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.